Page last updated: 2024-08-26

lopinavir and Spinal Cord Injuries

lopinavir has been researched along with Spinal Cord Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Del Popolo, G; Righi, G1
Barbonetti, A; Berardicurti, A; Berardicurti, O; D'Andrea, S; Felzani, G; Francavilla, F; Francavilla, S; Giacomelli, R1

Other Studies

2 other study(ies) available for lopinavir and Spinal Cord Injuries

ArticleYear
COVID-19 tsunami: the first case of a spinal cord injury patient in Italy.
    Spinal cord series and cases, 2020, 04-17, Volume: 6, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Retroviral Agents; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Fever; Hospitalization; Humans; Italy; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Quadriplegia; Respiration, Artificial; Ritonavir; Severe acute respiratory syndrome-related coronavirus; Spinal Cord Injuries

2020
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
    Spinal cord series and cases, 2020, 08-04, Volume: 6, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Case-Control Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Prognosis; Rehabilitation Centers; Ritonavir; SARS-CoV-2; Spinal Cord Injuries

2020